Sanofi (SNYNF) EBT Margin (2009 - 2026)

Sanofi (SNYNF) has 18 years of EBT Margin data on file, last reported at 118.73% in Q1 2026.

• Quarterly EBT Margin fell 320.0% year-over-year to 118.73% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 171.21% (up 797.0% YoY) and the FY2025 annual result came in at 14.15%, down 215.0% from the prior year.
• EBT Margin improved to 118.73% in Q1 2026 per SNYNF's latest filing, from 140.64% in the prior quarter.
• The five-year high for EBT Margin was 379.33% in Q4 2024, with the low at 140.64% in Q4 2025.
• Average EBT Margin over 5 years is 122.36%, with a median of 120.94% recorded in 2023.
• Year-over-year, EBT Margin soared 26331 bps in 2024 and plunged 51996 bps in 2025.
• Sanofi's EBT Margin stood at 164.48% in 2022, then slipped by 29 bps to 116.02% in 2023, then surged by 227 bps to 379.33% in 2024, then tumbled by 137 bps to 140.64% in 2025, then soared by 184 bps to 118.73% in 2026.
• Business Quant data shows SNYNF's EBT Margin at 118.73% in Q1 2026, 140.64% in Q4 2025, and 119.9% in Q3 2025.